Corbus Pharmaceuticals Holdings Inc (CRBP)
42.92
-0.85
(-1.94%)
USD |
NASDAQ |
May 10, 16:00
42.01
-0.91
(-2.12%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Cash from Operations (TTM): -36.10M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -36.10M |
September 30, 2023 | -37.55M |
June 30, 2023 | -37.62M |
March 31, 2023 | -42.04M |
December 31, 2022 | -37.54M |
September 30, 2022 | -39.79M |
June 30, 2022 | -31.69M |
March 31, 2022 | -36.99M |
December 31, 2021 | -48.18M |
September 30, 2021 | -56.71M |
June 30, 2021 | -84.82M |
March 31, 2021 | -93.89M |
December 31, 2020 | -99.69M |
September 30, 2020 | -104.02M |
June 30, 2020 | -93.86M |
March 31, 2020 | -83.64M |
December 31, 2019 | -45.72M |
September 30, 2019 | -37.22M |
June 30, 2019 | -28.98M |
Date | Value |
---|---|
March 31, 2019 | -18.15M |
December 31, 2018 | -30.07M |
September 30, 2018 | -25.12M |
June 30, 2018 | -22.60M |
March 31, 2018 | -22.76M |
December 31, 2017 | -27.80M |
September 30, 2017 | -24.16M |
June 30, 2017 | -20.88M |
March 31, 2017 | -17.69M |
December 31, 2016 | -13.57M |
September 30, 2016 | -8.974M |
June 30, 2016 | -8.406M |
March 31, 2016 | -5.860M |
December 31, 2015 | -4.625M |
September 30, 2015 | -5.065M |
June 30, 2015 | -3.160M |
March 31, 2015 | -3.501M |
December 31, 2014 | -2.361M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-104.02M
Minimum
Sep 2020
-28.98M
Maximum
Jun 2019
-56.63M
Average
-42.04M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
AIM ImmunoTech Inc | -21.27M |
Perspective Therapeutics Inc | -36.91M |
Protalix BioTherapeutics Inc | -1.318M |
Electromed Inc | 4.872M |
Armata Pharmaceuticals Inc | -47.42M |